nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—Gemcitabine—breast cancer	0.204	1	CrCtD
Cytarabine—CDA—breast cancer	0.115	0.909	CbGaD
Cytarabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—breast cancer	0.109	0.34	CiPCiCtD
Cytarabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—breast cancer	0.109	0.34	CiPCiCtD
Cytarabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—breast cancer	0.102	0.32	CiPCiCtD
Cytarabine—Lamivudine—Gemcitabine—breast cancer	0.0443	0.379	CrCrCtD
Cytarabine—Zalcitabine—Gemcitabine—breast cancer	0.0383	0.328	CrCrCtD
Cytarabine—POLD1—Gemcitabine—breast cancer	0.0318	0.181	CbGbCtD
Cytarabine—CDA—Capecitabine—breast cancer	0.0263	0.15	CbGbCtD
Cytarabine—POLE—Gemcitabine—breast cancer	0.023	0.131	CbGbCtD
Cytarabine—CDA—Gemcitabine—breast cancer	0.0182	0.104	CbGbCtD
Cytarabine—Azacitidine—Gemcitabine—breast cancer	0.0175	0.15	CrCrCtD
Cytarabine—Decitabine—Gemcitabine—breast cancer	0.0166	0.143	CrCrCtD
Cytarabine—POLA1—Gemcitabine—breast cancer	0.0132	0.0753	CbGbCtD
Cytarabine—CYP3A4—breast cancer	0.0114	0.0902	CbGaD
Cytarabine—SLC29A1—Gemcitabine—breast cancer	0.00877	0.05	CbGbCtD
Cytarabine—DCK—Gemcitabine—breast cancer	0.00812	0.0464	CbGbCtD
Cytarabine—SLC29A1—Fluorouracil—breast cancer	0.0075	0.0428	CbGbCtD
Cytarabine—ABCC10—Gemcitabine—breast cancer	0.0067	0.0382	CbGbCtD
Cytarabine—ABCC10—Paclitaxel—breast cancer	0.00605	0.0345	CbGbCtD
Cytarabine—ABCC10—Docetaxel—breast cancer	0.00437	0.025	CbGbCtD
Cytarabine—ABCC10—Doxorubicin—breast cancer	0.00326	0.0186	CbGbCtD
Cytarabine—ABCC10—Methotrexate—breast cancer	0.00316	0.018	CbGbCtD
Cytarabine—SLC22A2—Vinblastine—breast cancer	0.00186	0.0106	CbGbCtD
Cytarabine—CYP3A4—Exemestane—breast cancer	0.00171	0.00978	CbGbCtD
Cytarabine—CYP3A4—Letrozole—breast cancer	0.00146	0.00832	CbGbCtD
Cytarabine—CYP3A4—Anastrozole—breast cancer	0.0013	0.00741	CbGbCtD
Cytarabine—CYP3A4—Toremifene—breast cancer	0.00119	0.00678	CbGbCtD
Cytarabine—CYP3A4—Fulvestrant—breast cancer	0.0011	0.0063	CbGbCtD
Cytarabine—CYP3A4—Thiotepa—breast cancer	0.000984	0.00562	CbGbCtD
Cytarabine—CYP3A4—Ixabepilone—breast cancer	0.0009	0.00514	CbGbCtD
Cytarabine—CYP3A4—Lapatinib—breast cancer	0.000867	0.00495	CbGbCtD
Cytarabine—CYP3A4—Raloxifene—breast cancer	0.000657	0.00375	CbGbCtD
Cytarabine—DCTD—mammary gland—breast cancer	0.000597	0.0288	CbGeAlD
Cytarabine—DCTD—nipple—breast cancer	0.000494	0.0238	CbGeAlD
Cytarabine—CYP3A4—Vinorelbine—breast cancer	0.000481	0.00274	CbGbCtD
Cytarabine—NT5E—mammary gland—breast cancer	0.000462	0.0223	CbGeAlD
Cytarabine—POLE—mammary gland—breast cancer	0.000452	0.0218	CbGeAlD
Cytarabine—CYP3A4—Tamoxifen—breast cancer	0.000434	0.00248	CbGbCtD
Cytarabine—CYP3A4—Mitoxantrone—breast cancer	0.000423	0.00242	CbGbCtD
Cytarabine—POLB—skin of body—breast cancer	0.000392	0.0189	CbGeAlD
Cytarabine—POLA1—mammary gland—breast cancer	0.00039	0.0188	CbGeAlD
Cytarabine—POLE—nipple—breast cancer	0.000374	0.0181	CbGeAlD
Cytarabine—CYP3A4—Paclitaxel—breast cancer	0.000338	0.00193	CbGbCtD
Cytarabine—POLB—pituitary gland—breast cancer	0.000335	0.0162	CbGeAlD
Cytarabine—CYP3A4—Irinotecan—breast cancer	0.000333	0.0019	CbGbCtD
Cytarabine—POLB—adipose tissue—breast cancer	0.000333	0.0161	CbGeAlD
Cytarabine—POLD1—skin of body—breast cancer	0.00032	0.0155	CbGeAlD
Cytarabine—NT5E—embryo—breast cancer	0.000315	0.0152	CbGeAlD
Cytarabine—POLE—embryo—breast cancer	0.000309	0.0149	CbGeAlD
Cytarabine—POLB—female reproductive system—breast cancer	0.000306	0.0148	CbGeAlD
Cytarabine—POLB—adrenal gland—breast cancer	0.000299	0.0144	CbGeAlD
Cytarabine—DCTD—endometrium—breast cancer	0.000298	0.0144	CbGeAlD
Cytarabine—CYP3A4—Vinblastine—breast cancer	0.000296	0.00169	CbGbCtD
Cytarabine—POLB—bone marrow—breast cancer	0.000289	0.014	CbGeAlD
Cytarabine—POLB—female gonad—breast cancer	0.000279	0.0135	CbGeAlD
Cytarabine—POLD1—uterus—breast cancer	0.000278	0.0134	CbGeAlD
Cytarabine—DCTD—uterus—breast cancer	0.000275	0.0133	CbGeAlD
Cytarabine—POLD1—adipose tissue—breast cancer	0.000272	0.0131	CbGeAlD
Cytarabine—CDA—endometrium—breast cancer	0.000271	0.0131	CbGeAlD
Cytarabine—DCTD—pituitary gland—breast cancer	0.00027	0.013	CbGeAlD
Cytarabine—DCTD—adipose tissue—breast cancer	0.000269	0.013	CbGeAlD
Cytarabine—POLB—endocrine gland—breast cancer	0.000259	0.0125	CbGeAlD
Cytarabine—NT5E—epithelium—breast cancer	0.000257	0.0124	CbGeAlD
Cytarabine—SLC29A1—mammary gland—breast cancer	0.000252	0.0121	CbGeAlD
Cytarabine—POLD1—female reproductive system—breast cancer	0.00025	0.0121	CbGeAlD
Cytarabine—DCTD—female reproductive system—breast cancer	0.000247	0.0119	CbGeAlD
Cytarabine—NT5E—skin of body—breast cancer	0.000244	0.0118	CbGeAlD
Cytarabine—CDA—adipose tissue—breast cancer	0.000244	0.0118	CbGeAlD
Cytarabine—CYP3A4—Docetaxel—breast cancer	0.000244	0.00139	CbGbCtD
Cytarabine—POLD1—adrenal gland—breast cancer	0.000244	0.0118	CbGeAlD
Cytarabine—DCTD—adrenal gland—breast cancer	0.000241	0.0116	CbGeAlD
Cytarabine—DCTD—bone marrow—breast cancer	0.000233	0.0113	CbGeAlD
Cytarabine—NT5E—endometrium—breast cancer	0.000231	0.0111	CbGeAlD
Cytarabine—POLD1—female gonad—breast cancer	0.000228	0.011	CbGeAlD
Cytarabine—POLE—endometrium—breast cancer	0.000226	0.0109	CbGeAlD
Cytarabine—DCTD—female gonad—breast cancer	0.000225	0.0108	CbGeAlD
Cytarabine—CDA—adrenal gland—breast cancer	0.000219	0.0106	CbGeAlD
Cytarabine—NT5E—uterus—breast cancer	0.000212	0.0103	CbGeAlD
Cytarabine—CDA—bone marrow—breast cancer	0.000212	0.0102	CbGeAlD
Cytarabine—DCTD—endocrine gland—breast cancer	0.000209	0.0101	CbGeAlD
Cytarabine—NT5E—pituitary gland—breast cancer	0.000209	0.0101	CbGeAlD
Cytarabine—SLC29A1—nipple—breast cancer	0.000208	0.01	CbGeAlD
Cytarabine—NT5E—adipose tissue—breast cancer	0.000208	0.01	CbGeAlD
Cytarabine—POLE—pituitary gland—breast cancer	0.000204	0.00987	CbGeAlD
Cytarabine—POLE—adipose tissue—breast cancer	0.000204	0.00983	CbGeAlD
Cytarabine—DCK—nipple—breast cancer	0.000199	0.0096	CbGeAlD
Cytarabine—POLA1—endometrium—breast cancer	0.000195	0.0094	CbGeAlD
Cytarabine—NT5E—female reproductive system—breast cancer	0.000191	0.00922	CbGeAlD
Cytarabine—CDA—endocrine gland—breast cancer	0.00019	0.00918	CbGeAlD
Cytarabine—ABCC10—nipple—breast cancer	0.000189	0.00914	CbGeAlD
Cytarabine—POLE—female reproductive system—breast cancer	0.000187	0.00903	CbGeAlD
Cytarabine—NT5E—adrenal gland—breast cancer	0.000186	0.009	CbGeAlD
Cytarabine—POLE—adrenal gland—breast cancer	0.000183	0.00881	CbGeAlD
Cytarabine—CYP3A4—Doxorubicin—breast cancer	0.000182	0.00104	CbGbCtD
Cytarabine—NT5E—bone marrow—breast cancer	0.00018	0.0087	CbGeAlD
Cytarabine—POLB—lymph node—breast cancer	0.000179	0.00865	CbGeAlD
Cytarabine—POLE—bone marrow—breast cancer	0.000177	0.00853	CbGeAlD
Cytarabine—POLA1—pituitary gland—breast cancer	0.000176	0.0085	CbGeAlD
Cytarabine—POLA1—adipose tissue—breast cancer	0.000175	0.00847	CbGeAlD
Cytarabine—NT5E—female gonad—breast cancer	0.000174	0.00839	CbGeAlD
Cytarabine—POLE—female gonad—breast cancer	0.00017	0.00822	CbGeAlD
Cytarabine—DCK—embryo—breast cancer	0.000164	0.00792	CbGeAlD
Cytarabine—Gemcitabine—SLC28A1—breast cancer	0.000162	0.107	CrCbGaD
Cytarabine—NT5E—endocrine gland—breast cancer	0.000162	0.0078	CbGeAlD
Cytarabine—POLE—endocrine gland—breast cancer	0.000158	0.00764	CbGeAlD
Cytarabine—POLA1—adrenal gland—breast cancer	0.000157	0.0076	CbGeAlD
Cytarabine—POLA1—bone marrow—breast cancer	0.000152	0.00735	CbGeAlD
Cytarabine—Azacitidine—DNMT3A—breast cancer	0.000147	0.0971	CrCbGaD
Cytarabine—POLA1—female gonad—breast cancer	0.000147	0.00708	CbGeAlD
Cytarabine—POLD1—lymph node—breast cancer	0.000146	0.00707	CbGeAlD
Cytarabine—DCTD—lymph node—breast cancer	0.000144	0.00697	CbGeAlD
Cytarabine—Decitabine—DNMT3A—breast cancer	0.000143	0.0948	CrCbGaD
Cytarabine—CDA—lymph node—breast cancer	0.000131	0.00634	CbGeAlD
Cytarabine—Azacitidine—CDA—breast cancer	0.000131	0.0865	CrCbGaD
Cytarabine—SLC29A1—endometrium—breast cancer	0.000126	0.00606	CbGeAlD
Cytarabine—DCK—endometrium—breast cancer	0.00012	0.00579	CbGeAlD
Cytarabine—DCK—Topotecan—Irinotecan—breast cancer	0.000119	0.154	CbGdCrCtD
Cytarabine—SLC29A1—uterus—breast cancer	0.000116	0.00559	CbGeAlD
Cytarabine—ABCC10—endometrium—breast cancer	0.000114	0.00552	CbGeAlD
Cytarabine—SLC29A1—pituitary gland—breast cancer	0.000114	0.00549	CbGeAlD
Cytarabine—SLC29A1—adipose tissue—breast cancer	0.000113	0.00547	CbGeAlD
Cytarabine—POLA1—Vinblastine—Vinorelbine—breast cancer	0.000112	0.145	CbGdCrCtD
Cytarabine—Lamivudine—NME1—breast cancer	0.000112	0.0739	CrCbGaD
Cytarabine—NT5E—lymph node—breast cancer	0.000112	0.00539	CbGeAlD
Cytarabine—DCK—uterus—breast cancer	0.000111	0.00534	CbGeAlD
Cytarabine—Gemcitabine—CDA—breast cancer	0.000109	0.0724	CrCbGaD
Cytarabine—POLE—lymph node—breast cancer	0.000109	0.00528	CbGeAlD
Cytarabine—DCK—pituitary gland—breast cancer	0.000109	0.00524	CbGeAlD
Cytarabine—DCK—adipose tissue—breast cancer	0.000108	0.00522	CbGeAlD
Cytarabine—ABCC10—uterus—breast cancer	0.000105	0.00509	CbGeAlD
Cytarabine—SLC29A1—female reproductive system—breast cancer	0.000104	0.00502	CbGeAlD
Cytarabine—ABCC10—pituitary gland—breast cancer	0.000103	0.005	CbGeAlD
Cytarabine—ABCC10—adipose tissue—breast cancer	0.000103	0.00497	CbGeAlD
Cytarabine—SLC29A1—adrenal gland—breast cancer	0.000102	0.0049	CbGeAlD
Cytarabine—DCK—female reproductive system—breast cancer	9.94e-05	0.0048	CbGeAlD
Cytarabine—POLD1—Danazol—Fluoxymesterone—breast cancer	9.89e-05	0.128	CbGdCrCtD
Cytarabine—SLC29A1—bone marrow—breast cancer	9.82e-05	0.00474	CbGeAlD
Cytarabine—DCK—adrenal gland—breast cancer	9.7e-05	0.00468	CbGeAlD
Cytarabine—ABCC10—female reproductive system—breast cancer	9.47e-05	0.00457	CbGeAlD
Cytarabine—SLC29A1—female gonad—breast cancer	9.47e-05	0.00457	CbGeAlD
Cytarabine—POLA1—lymph node—breast cancer	9.43e-05	0.00455	CbGeAlD
Cytarabine—DCK—bone marrow—breast cancer	9.39e-05	0.00453	CbGeAlD
Cytarabine—ABCC10—adrenal gland—breast cancer	9.24e-05	0.00446	CbGeAlD
Cytarabine—SLC22A1—adipose tissue—breast cancer	9.22e-05	0.00445	CbGeAlD
Cytarabine—DCK—female gonad—breast cancer	9.05e-05	0.00437	CbGeAlD
Cytarabine—ABCC10—bone marrow—breast cancer	8.94e-05	0.00432	CbGeAlD
Cytarabine—Adenosine monophosphate—PIM1—breast cancer	8.9e-05	0.0588	CrCbGaD
Cytarabine—SLC29A1—endocrine gland—breast cancer	8.81e-05	0.00425	CbGeAlD
Cytarabine—ABCC10—female gonad—breast cancer	8.62e-05	0.00416	CbGeAlD
Cytarabine—DCK—endocrine gland—breast cancer	8.41e-05	0.00406	CbGeAlD
Cytarabine—ABCC10—endocrine gland—breast cancer	8.01e-05	0.00387	CbGeAlD
Cytarabine—Azacitidine—DNMT1—breast cancer	7.93e-05	0.0524	CrCbGaD
Cytarabine—Decitabine—DNMT1—breast cancer	7.74e-05	0.0512	CrCbGaD
Cytarabine—POLD1—Azacitidine—Gemcitabine—breast cancer	7.65e-05	0.0991	CbGdCrCtD
Cytarabine—Adenosine monophosphate—APRT—breast cancer	7.56e-05	0.05	CrCbGaD
Cytarabine—SLC22A1—endocrine gland—breast cancer	7.17e-05	0.00346	CbGeAlD
Cytarabine—Glucosamine—IFNG—breast cancer	6.74e-05	0.0446	CrCbGaD
Cytarabine—POLA1—Norethindrone—Fluoxymesterone—breast cancer	6.1e-05	0.0791	CbGdCrCtD
Cytarabine—SLC29A1—lymph node—breast cancer	6.09e-05	0.00294	CbGeAlD
Cytarabine—DCK—Epirubicin—Idarubicin—breast cancer	6.09e-05	0.0788	CbGdCrCtD
Cytarabine—DCK—Doxorubicin—Idarubicin—breast cancer	6.09e-05	0.0788	CbGdCrCtD
Cytarabine—DCK—Clomifene—Toremifene—breast cancer	5.83e-05	0.0755	CbGdCrCtD
Cytarabine—DCK—lymph node—breast cancer	5.82e-05	0.00281	CbGeAlD
Cytarabine—ABCC10—lymph node—breast cancer	5.54e-05	0.00267	CbGeAlD
Cytarabine—Glucosamine—MMP9—breast cancer	4.3e-05	0.0284	CrCbGaD
Cytarabine—CYP3A4—female reproductive system—breast cancer	3.86e-05	0.00187	CbGeAlD
Cytarabine—Lamivudine—ABCC1—breast cancer	3.75e-05	0.0248	CrCbGaD
Cytarabine—DCK—Clomifene—Tamoxifen—breast cancer	3.66e-05	0.0474	CbGdCrCtD
Cytarabine—Gemcitabine—TYMS—breast cancer	3.57e-05	0.0236	CrCbGaD
Cytarabine—DCK—Desoximetasone—Fluoxymesterone—breast cancer	3.43e-05	0.0444	CbGdCrCtD
Cytarabine—CYP3A4—endocrine gland—breast cancer	3.27e-05	0.00158	CbGeAlD
Cytarabine—S-Adenosylmethionine—COMT—breast cancer	3.2e-05	0.0212	CrCbGaD
Cytarabine—Adenosine monophosphate—PDE4D—breast cancer	3.12e-05	0.0206	CrCbGaD
Cytarabine—Glucosamine—TNF—breast cancer	2.82e-05	0.0187	CrCbGaD
Cytarabine—DCK—Doxorubicin—Epirubicin—breast cancer	2.79e-05	0.0362	CbGdCrCtD
Cytarabine—Adenosine monophosphate—SRC—breast cancer	2.73e-05	0.018	CrCbGaD
Cytarabine—DCK—Epirubicin—Doxorubicin—breast cancer	2.59e-05	0.0335	CbGdCrCtD
Cytarabine—Clofarabine—ABCG2—breast cancer	2.38e-05	0.0157	CrCbGaD
Cytarabine—Lamivudine—ABCG2—breast cancer	1.98e-05	0.0131	CrCbGaD
Cytarabine—Zalcitabine—CYP2D6—breast cancer	1.29e-05	0.00851	CrCbGaD
Cytarabine—Zalcitabine—CYP3A4—breast cancer	1.1e-05	0.0073	CrCbGaD
Cytarabine—Gemcitabine—ABCB1—breast cancer	9.04e-06	0.00598	CrCbGaD
Cytarabine—Lamivudine—ABCB1—breast cancer	8.23e-06	0.00544	CrCbGaD
Cytarabine—SLC22A2—Metabolism—GSTA2—breast cancer	1.62e-06	4.7e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GPX2—breast cancer	1.62e-06	4.7e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—COMT—breast cancer	1.62e-06	4.69e-05	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN1A—breast cancer	1.62e-06	4.69e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	1.61e-06	4.67e-05	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—breast cancer	1.6e-06	4.64e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GPX4—breast cancer	1.6e-06	4.64e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SULT1A1—breast cancer	1.6e-06	4.64e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CAV1—breast cancer	1.57e-06	4.55e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ABCB1—breast cancer	1.56e-06	4.53e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GSTA1—breast cancer	1.56e-06	4.53e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—IDH1—breast cancer	1.56e-06	4.53e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CA9—breast cancer	1.55e-06	4.49e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTA4—breast cancer	1.55e-06	4.49e-05	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—breast cancer	1.54e-06	4.48e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NAT2—breast cancer	1.54e-06	4.48e-05	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MAPK3—breast cancer	1.54e-06	4.47e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CG—breast cancer	1.52e-06	4.41e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTA2—breast cancer	1.51e-06	4.38e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GPX2—breast cancer	1.51e-06	4.38e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.5e-06	4.35e-05	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MYC—breast cancer	1.5e-06	4.35e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GPX4—breast cancer	1.49e-06	4.32e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SULT1A1—breast cancer	1.49e-06	4.32e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.48e-06	4.29e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTA1—breast cancer	1.46e-06	4.22e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—IDH1—breast cancer	1.46e-06	4.22e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NAT2—breast cancer	1.44e-06	4.17e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CG—breast cancer	1.43e-06	4.15e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.42e-06	4.13e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.4e-06	4.07e-05	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MAPK3—breast cancer	1.38e-06	4e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MED12—breast cancer	1.35e-06	3.93e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—DPYD—breast cancer	1.35e-06	3.93e-05	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MYC—breast cancer	1.34e-06	3.89e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CD—breast cancer	1.34e-06	3.88e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ALDOA—breast cancer	1.33e-06	3.87e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ALB—breast cancer	1.32e-06	3.83e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NCOA3—breast cancer	1.29e-06	3.75e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SLC2A2—breast cancer	1.28e-06	3.73e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—HRAS—breast cancer	1.27e-06	3.68e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—NOS3—breast cancer	1.26e-06	3.66e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—DPYD—breast cancer	1.26e-06	3.66e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MED12—breast cancer	1.26e-06	3.66e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ABCG2—breast cancer	1.26e-06	3.65e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MTR—breast cancer	1.26e-06	3.65e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CPT1A—breast cancer	1.26e-06	3.65e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CD—breast cancer	1.26e-06	3.65e-05	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CA—breast cancer	1.25e-06	3.63e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ALDOA—breast cancer	1.24e-06	3.6e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ALB—breast cancer	1.24e-06	3.6e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—HPGDS—breast cancer	1.23e-06	3.58e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—HBA1—breast cancer	1.23e-06	3.56e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NCOA3—breast cancer	1.21e-06	3.5e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SLC2A2—breast cancer	1.2e-06	3.47e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ACHE—breast cancer	1.2e-06	3.47e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GSTT1—breast cancer	1.2e-06	3.47e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—NOS3—breast cancer	1.19e-06	3.44e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—HRAS—breast cancer	1.18e-06	3.43e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ABCG2—breast cancer	1.17e-06	3.4e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CPT1A—breast cancer	1.17e-06	3.4e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MTR—breast cancer	1.17e-06	3.4e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CB—breast cancer	1.17e-06	3.38e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS2—breast cancer	1.15e-06	3.35e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—HPGDS—breast cancer	1.15e-06	3.34e-05	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CA—breast cancer	1.15e-06	3.32e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SYNJ2—breast cancer	1.14e-06	3.32e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—HBA1—breast cancer	1.14e-06	3.32e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP17A1—breast cancer	1.13e-06	3.29e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ENO1—breast cancer	1.12e-06	3.25e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS1—breast cancer	1.12e-06	3.25e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ACHE—breast cancer	1.12e-06	3.24e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTT1—breast cancer	1.12e-06	3.24e-05	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—breast cancer	1.1e-06	3.19e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP2D6—breast cancer	1.1e-06	3.19e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CB—breast cancer	1.1e-06	3.18e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS2—breast cancer	1.09e-06	3.15e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NCOA2—breast cancer	1.08e-06	3.13e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NDUFS3—breast cancer	1.06e-06	3.09e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP17A1—breast cancer	1.06e-06	3.06e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—ALB—breast cancer	1.05e-06	3.04e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—FASN—breast cancer	1.05e-06	3.04e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ENO1—breast cancer	1.05e-06	3.03e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS1—breast cancer	1.05e-06	3.03e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—BCHE—breast cancer	1.04e-06	3.03e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SLC5A5—breast cancer	1.03e-06	2.99e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP2D6—breast cancer	1.03e-06	2.97e-05	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AKT1—breast cancer	1.02e-06	2.97e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTEN—breast cancer	1.01e-06	2.92e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NCOA2—breast cancer	1.01e-06	2.92e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CHST9—breast cancer	1e-06	2.9e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NQO1—breast cancer	9.95e-07	2.89e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SLC2A1—breast cancer	9.95e-07	2.89e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ALB—breast cancer	9.78e-07	2.84e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—FASN—breast cancer	9.76e-07	2.83e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—BCHE—breast cancer	9.72e-07	2.82e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—HRAS—breast cancer	9.72e-07	2.82e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP3A4—breast cancer	9.7e-07	2.81e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SLC5A5—breast cancer	9.6e-07	2.79e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP1B1—breast cancer	9.54e-07	2.77e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—RAF1—breast cancer	9.49e-07	2.75e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—COX11—breast cancer	9.48e-07	2.75e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTEN—breast cancer	9.47e-07	2.75e-05	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AKT1—breast cancer	9.35e-07	2.71e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—HSP90AA1—breast cancer	9.35e-07	2.71e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NQO1—breast cancer	9.27e-07	2.69e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SLC2A1—breast cancer	9.27e-07	2.69e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NCOA1—breast cancer	9.1e-07	2.64e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—HRAS—breast cancer	9.06e-07	2.63e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP3A4—breast cancer	9.04e-07	2.62e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—STK11—breast cancer	8.97e-07	2.6e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP19A1—breast cancer	8.97e-07	2.6e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP1B1—breast cancer	8.89e-07	2.58e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—RAF1—breast cancer	8.84e-07	2.57e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—HSP90AA1—breast cancer	8.72e-07	2.53e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SHMT1—breast cancer	8.67e-07	2.52e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CDA—breast cancer	8.67e-07	2.52e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NCOA1—breast cancer	8.48e-07	2.46e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—STK11—breast cancer	8.36e-07	2.42e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP19A1—breast cancer	8.36e-07	2.42e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLCO1B1—breast cancer	8.35e-07	2.42e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC2A5—breast cancer	8.35e-07	2.42e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—COMT—breast cancer	8.34e-07	2.42e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GSTP1—breast cancer	8.3e-07	2.41e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—HMOX1—breast cancer	8.18e-07	2.37e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ITPR1—breast cancer	8.17e-07	2.37e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—APRT—breast cancer	8.06e-07	2.34e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ABCB1—breast cancer	7.85e-07	2.28e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—COMT—breast cancer	7.77e-07	2.25e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTP1—breast cancer	7.73e-07	2.24e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—TYMS—breast cancer	7.71e-07	2.24e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—HMOX1—breast cancer	7.63e-07	2.21e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GSTM1—breast cancer	7.63e-07	2.21e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PLA2G4A—breast cancer	7.63e-07	2.21e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NCOR1—breast cancer	7.63e-07	2.21e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ITPR1—breast cancer	7.61e-07	2.21e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ESRRA—breast cancer	7.58e-07	2.2e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ANGPTL4—breast cancer	7.58e-07	2.2e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ABCB1—breast cancer	7.32e-07	2.12e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GPX1—breast cancer	7.3e-07	2.12e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP1A1—breast cancer	7.23e-07	2.1e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—TYMS—breast cancer	7.19e-07	2.09e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—HADHB—breast cancer	7.19e-07	2.09e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GPI—breast cancer	7.19e-07	2.09e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ERCC2—breast cancer	7.17e-07	2.08e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NCOR1—breast cancer	7.11e-07	2.06e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PLA2G4A—breast cancer	7.11e-07	2.06e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTM1—breast cancer	7.11e-07	2.06e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CA—breast cancer	7.1e-07	2.06e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ALDH7A1—breast cancer	6.86e-07	1.99e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ALDH1A1—breast cancer	6.86e-07	1.99e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GPX1—breast cancer	6.81e-07	1.97e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MTHFR—breast cancer	6.74e-07	1.96e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP1A1—breast cancer	6.74e-07	1.95e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ERCC2—breast cancer	6.68e-07	1.94e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CA—breast cancer	6.68e-07	1.94e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PHGDH—breast cancer	6.57e-07	1.91e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NME1—breast cancer	6.57e-07	1.91e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ADSL—breast cancer	6.57e-07	1.91e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—FHL2—breast cancer	6.57e-07	1.91e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—UMPS—breast cancer	6.57e-07	1.91e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—HPSE—breast cancer	6.45e-07	1.87e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—BRIP1—breast cancer	6.45e-07	1.87e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—LDHB—breast cancer	6.45e-07	1.87e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MTHFR—breast cancer	6.28e-07	1.82e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CAV1—breast cancer	6.22e-07	1.8e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ABCC1—breast cancer	6.11e-07	1.77e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—HMMR—breast cancer	6.11e-07	1.77e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTA3—breast cancer	6.11e-07	1.77e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.92e-07	1.72e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKT1—breast cancer	5.8e-07	1.68e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CAV1—breast cancer	5.79e-07	1.68e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CG—breast cancer	5.66e-07	1.64e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTA4—breast cancer	5.59e-07	1.62e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CA9—breast cancer	5.59e-07	1.62e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKT1—breast cancer	5.46e-07	1.58e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GPX2—breast cancer	5.45e-07	1.58e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTA2—breast cancer	5.45e-07	1.58e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GPX4—breast cancer	5.38e-07	1.56e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SULT1A1—breast cancer	5.38e-07	1.56e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CG—breast cancer	5.28e-07	1.53e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTA1—breast cancer	5.26e-07	1.52e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—IDH1—breast cancer	5.26e-07	1.52e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NAT2—breast cancer	5.2e-07	1.51e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CD—breast cancer	4.98e-07	1.44e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ALB—breast cancer	4.91e-07	1.43e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NOS3—breast cancer	4.7e-07	1.36e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CD—breast cancer	4.64e-07	1.35e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ALB—breast cancer	4.58e-07	1.33e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MED12—breast cancer	4.56e-07	1.32e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—DPYD—breast cancer	4.56e-07	1.32e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ALDOA—breast cancer	4.49e-07	1.3e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NOS3—breast cancer	4.38e-07	1.27e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NCOA3—breast cancer	4.35e-07	1.26e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CB—breast cancer	4.34e-07	1.26e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC2A2—breast cancer	4.32e-07	1.25e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS2—breast cancer	4.3e-07	1.25e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ABCG2—breast cancer	4.24e-07	1.23e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CPT1A—breast cancer	4.24e-07	1.23e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MTR—breast cancer	4.24e-07	1.23e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—HPGDS—breast cancer	4.15e-07	1.21e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—HBA1—breast cancer	4.13e-07	1.2e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CB—breast cancer	4.04e-07	1.17e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTT1—breast cancer	4.03e-07	1.17e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ACHE—breast cancer	4.03e-07	1.17e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS2—breast cancer	4.01e-07	1.16e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP17A1—breast cancer	3.81e-07	1.11e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ENO1—breast cancer	3.78e-07	1.1e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS1—breast cancer	3.78e-07	1.1e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTEN—breast cancer	3.75e-07	1.09e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP2D6—breast cancer	3.7e-07	1.07e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NCOA2—breast cancer	3.63e-07	1.05e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—FASN—breast cancer	3.52e-07	1.02e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—BCHE—breast cancer	3.51e-07	1.02e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTEN—breast cancer	3.49e-07	1.01e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC5A5—breast cancer	3.47e-07	1.01e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC2A1—breast cancer	3.35e-07	9.71e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NQO1—breast cancer	3.35e-07	9.71e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP1B1—breast cancer	3.21e-07	9.31e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.15e-07	9.13e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NCOA1—breast cancer	3.06e-07	8.89e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—STK11—breast cancer	3.02e-07	8.76e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP19A1—breast cancer	3.02e-07	8.76e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—COMT—breast cancer	2.81e-07	8.14e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTP1—breast cancer	2.79e-07	8.1e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—HMOX1—breast cancer	2.75e-07	7.99e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ITPR1—breast cancer	2.75e-07	7.97e-06	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CA—breast cancer	2.64e-07	7.67e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ABCB1—breast cancer	2.64e-07	7.67e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—TYMS—breast cancer	2.6e-07	7.53e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.57e-07	7.45e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTM1—breast cancer	2.57e-07	7.45e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NCOR1—breast cancer	2.57e-07	7.45e-06	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CA—breast cancer	2.47e-07	7.15e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GPX1—breast cancer	2.46e-07	7.13e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP1A1—breast cancer	2.43e-07	7.06e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ERCC2—breast cancer	2.41e-07	7e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MTHFR—breast cancer	2.27e-07	6.58e-06	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKT1—breast cancer	2.16e-07	6.27e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CAV1—breast cancer	2.09e-07	6.07e-06	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKT1—breast cancer	2.01e-07	5.84e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.91e-07	5.53e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.68e-07	4.86e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ALB—breast cancer	1.65e-07	4.8e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NOS3—breast cancer	1.58e-07	4.59e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.46e-07	4.24e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS2—breast cancer	1.45e-07	4.2e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTEN—breast cancer	1.26e-07	3.66e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CA—breast cancer	8.9e-08	2.58e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKT1—breast cancer	7.27e-08	2.11e-06	CbGpPWpGaD
